Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2008 1
2009 1
2011 1
2013 1
2015 2
2016 5
2017 4
2018 3
2019 4
2020 4
2021 3
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
The adenosine pathway in immuno-oncology.
Allard B, Allard D, Buisseret L, Stagg J. Allard B, et al. Among authors: allard d. Nat Rev Clin Oncol. 2020 Oct;17(10):611-629. doi: 10.1038/s41571-020-0382-2. Epub 2020 Jun 8. Nat Rev Clin Oncol. 2020. PMID: 32514148 Review.
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.
Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Jacoberger-Foissac C, et al. Among authors: allard d. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. Cancer Immunol Res. 2023. PMID: 36409930 Free PMC article.
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA. Olive KP, et al. Among authors: allard d. Science. 2009 Jun 12;324(5933):1457-61. doi: 10.1126/science.1171362. Epub 2009 May 21. Science. 2009. PMID: 19460966 Free PMC article.
Design and implementation of a clinical decision support tool for primary palliative Care for Emergency Medicine (PRIM-ER).
Tan A, Durbin M, Chung FR, Rubin AL, Cuthel AM, McQuilkin JA, Modrek AS, Jamin C, Gavin N, Mann D, Swartz JL, Austrian JS, Testa PA, Hill JD, Grudzen CR; Group Authorship: Corita R. Grudzen on behalf of the PRIM-ER Clinical Informatics Advisory Board. Tan A, et al. BMC Med Inform Decis Mak. 2020 Jan 28;20(1):13. doi: 10.1186/s12911-020-1021-7. BMC Med Inform Decis Mak. 2020. PMID: 31992301 Free PMC article. Clinical Trial.
Targeting A2 adenosine receptors in cancer.
Allard D, Turcotte M, Stagg J. Allard D, et al. Immunol Cell Biol. 2017 Apr;95(4):333-339. doi: 10.1038/icb.2017.8. Epub 2017 Feb 8. Immunol Cell Biol. 2017. PMID: 28174424 Review.
Targeting the CD73-adenosine axis in immuno-oncology.
Allard D, Chrobak P, Allard B, Messaoudi N, Stagg J. Allard D, et al. Immunol Lett. 2019 Jan;205:31-39. doi: 10.1016/j.imlet.2018.05.001. Epub 2018 May 24. Immunol Lett. 2019. PMID: 29758241 Review.
Targeting the adenosine pathway for cancer immunotherapy.
Hammami A, Allard D, Allard B, Stagg J. Hammami A, et al. Among authors: allard d. Semin Immunol. 2019 Apr;42:101304. doi: 10.1016/j.smim.2019.101304. Semin Immunol. 2019. PMID: 31604539 Review.
CD73 Promotes Chronic Lymphocytic Leukemia.
Allard D, Chrobak P, Bareche Y, Allard B, Tessier P, Bergeron MA, Johnson NA, Stagg J. Allard D, et al. Cancers (Basel). 2022 Jun 26;14(13):3130. doi: 10.3390/cancers14133130. Cancers (Basel). 2022. PMID: 35804900 Free PMC article.
36 results